Table 1 Comparison of the developed biosensor and other different studies for the evaluation of CA15-3 biomarker.

From: Highly efficient electrochemical biosensing platform in breast cancer detection based on MOF-COF@Au core-shell like nanostructure

Electrode

Detection method

LOD/LLOQ

Linear range

Ref

SPCE/GO/MoSe2/P3ABA/ DAP-AuNPs/CA15-3/BSA/anti-CA15-3

CV, EIS

0.14 U/mL

0-500 U/mL

49

GCE Ag/TiO2/rGO/CA15-3

Amperometry

0.07 U/mL

0.1–300 U/mL

50

GCE/Au@Ag NPs/Ab/Ag/Ab/Hg2+ SiO2

DPV, EIS

0.05U/mL

0.1–200 U/mL

51

CNE/AuNP/MIP/CA15-3

CV

1.16 U/mL

5–35 U/mL

52

GCE/RGO-MoS2/ AuNPs/Apt/BSA/CA15-3

EIS

0.3 U/mL

5-200 U/mL

53

Ab2/CQDs-PEI-GO/AuNPs /CA15-3/BSA/Ab1/PDA-AgNPs/GCE

ECL

0.0017 U/mL

0.005-500 U/mL

54

GCE/3DGH/AuNPs/Aps/ BSA/CA15-3

DPV

0.112 U/mL

0.01–150 U/mL

55

AuSPE/MSA/EDC/Ab/EA

SWV

0.95 U/mL

1-1000 U/mL

56

e-PI/Au/Anti-CA15-3

DPV

0.15 U/mL

0.5–200 U/mL

57

GE/Strep/mAb/ BSA/ CA15-3

SWV

15*10−6 U/mL

15*10−6-50 U/mL

58

GCE/MIL-156 MOF@COF@Au/CA15-3

DPV

2.6nU/mL

30–100 nU/mL

This work